| Tracey Marie Osborne, CNP | |
|
2669 Scenic Dr, Alamogordo, NM 88310-8700 | |
| (575) 443-7854 | |
| Not Available |
| Full Name | Tracey Marie Osborne |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 2669 Scenic Dr, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346411683 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | CNP00676 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gerald Champion Regional Medical Center | Alamogordo, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Mountain Hospital Physicians, Pllc | 1052659737 | 19 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University of California, Irvine neurologist Steven C. Cramer, MD, at the recent 2018 European Stroke Organisation Conference in Gothenburg, Sweden.
Harmful flame retardants may be lurking on your hands and cell phone, according to a peer-reviewed study published today in Environmental Science & Technology Letters.
Pittcon 2017 brought together members from the scientific community from around the world with leading speakers, instructors and exhibiting companies.
› Verified 9 days ago
| Entity Name | Western Mountain Hospital Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992278360 PECOS PAC ID: 1052659737 Enrollment ID: O20220809002964 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University of California, Irvine neurologist Steven C. Cramer, MD, at the recent 2018 European Stroke Organisation Conference in Gothenburg, Sweden.
Harmful flame retardants may be lurking on your hands and cell phone, according to a peer-reviewed study published today in Environmental Science & Technology Letters.
Pittcon 2017 brought together members from the scientific community from around the world with leading speakers, instructors and exhibiting companies.
› Verified 9 days ago
| Entity Name | Four Corners Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144793464 PECOS PAC ID: 5092053769 Enrollment ID: O20220829003007 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University of California, Irvine neurologist Steven C. Cramer, MD, at the recent 2018 European Stroke Organisation Conference in Gothenburg, Sweden.
Harmful flame retardants may be lurking on your hands and cell phone, according to a peer-reviewed study published today in Environmental Science & Technology Letters.
Pittcon 2017 brought together members from the scientific community from around the world with leading speakers, instructors and exhibiting companies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tracey Marie Osborne, CNP 2669 Scenic Dr, Alamogordo, NM 88310-8700 Ph: (575) 449-6100 | Tracey Marie Osborne, CNP 2669 Scenic Dr, Alamogordo, NM 88310-8700 Ph: (575) 443-7854 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University of California, Irvine neurologist Steven C. Cramer, MD, at the recent 2018 European Stroke Organisation Conference in Gothenburg, Sweden.
Harmful flame retardants may be lurking on your hands and cell phone, according to a peer-reviewed study published today in Environmental Science & Technology Letters.
Pittcon 2017 brought together members from the scientific community from around the world with leading speakers, instructors and exhibiting companies.
› Verified 9 days ago
Sherry E Gill, CNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1410 Aspen Dr, Alamogordo, NM 88310 Phone: 575-437-7000 | |
Ms. Elaine M Neidert, MSN, PMHNP- BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-446-5300 Fax: 575-466-5304 | |
Heather Podhajecki, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-437-8126 |